Rising healthcare costs are forcing employers to rethink how they fund and manage employee benefits. As specialty drug spending, high-cost claims, and medical inflation continue to climb, many organizations are turning to employee benefits captives as a way to gain greater financial stability, improve data visibility, and better manage long-term healthcare costs. 

Employers are navigating a perfect storm of rising specialty drug spend, high-cost claims, and market volatility. Traditional funding models often leave organizations reacting to these pressures after the fact, with limited control over outcomes.  

But across the market, one trend is becoming increasingly clear: Captive models are outperforming—and not by accident.   

The reason isn’t a single lever. It’s a fundamentally different approach to managing risk, cost, and strategy.  

In a traditional model, employers typically learn about cost drivers after renewal. By then, options are often limited to plan design changes or cost shifting.  

Captives change that dynamic.  

By pooling data across multiple organizations, captives provide earlier visibility into emerging trends—such as oncology spend, musculoskeletal conditions, and specialty pharmacy utilization.   

This enables employers to:  

What we’re seeing in our own CaptuRe data reinforces this: Organizations that engage with their data and act on it are better positioned to manage rising costs.  

One of the biggest challenges in today’s market is volatility. A single high-cost claimant can dramatically impact an employer’s plan performance.  

Captives are structured differently. They spread risk across participants and layer in protections:  

In practice, this structure does exactly what it’s designed to do. For example, millions in high-cost claims have been transferred to excess layers—protecting individual employers from those spikes.    

The result is not necessarily lower costs every year but more consistent, manageable outcomes over time.  

Captives don’t just aggregate risk—they aggregate insight. Across captive populations, the data consistently shows that a small percentage of members drives a disproportionate share of spend.   

That level of transparency allows employers to move beyond broad cost containment strategies and focus on:  

This is a key differentiator. In a rising-cost market, precision matters more than blanket cost control.  

Pharmacy continues to be one of the fastest-growing cost drivers—particularly with specialty medications and emerging therapies. It’s also where captives are demonstrating measurable advantage.  

Within captive structures, employers have more flexibility and alignment to implement strategies such as:  

In our CaptuRe population, for example, pharmacy costs have decreased even as utilization increased—resulting in meaningfully lower cost levels compared to benchmarks.  This highlights a broader point: Cost trends are not inevitable—they’re influenced by strategy.  

The market is evolving quickly:  

Traditional models often struggle to adapt along with the market. Captives, however, allow for more coordinated responses across members—whether that’s adjusting pharmacy strategies, implementing new clinical programs, or aligning plan design changes.  

In short, captives create a data-rich environment where employers can share insight and act collectively, rather than navigating these challenges in isolation.  

Outperformance isn’t just about reducing cost—it’s about managing risk.  

Captives are designed with protection in mind:  

Even in years where claims increase, this structure helps prevent large, unexpected financial swings at the individual employer level. That level of protection is becoming more valuable as claim severity continues to rise.  

A captive model shifts decision-making by fueling it with greater insight and flexibility, creating alignment across participants. In a captive model:  

This creates a fundamentally different operating model—one where decisions are driven by long-term performance rather than short-term reaction.  

Our experience with CaptuRe continues to reinforce this: Organizations that lean into the model—engaging with data, strategy, and execution—see stronger, more stable outcomes even as the broader market faces increasing pressure.   

Rising healthcare costs aren’t going away—but how organizations respond to them is evolving.  

Captives don’t eliminate risk or cost pressures. What they do is provide:  

In a market defined by uncertainty, that combination keeps captives ahead of the curve.